|
|||||||||||||||||||||||||
![]() |
ThursdayBiogen Idec Finds That Nogo Receptor Could Play a Role in the Progression of Parkinson's Disease
This research, discovered by a team of Biogen Idec-led scientists, is the first to suggest that inhibiting the Nogo-66 receptor (NgR1) may provide therapeutic benefit in the treatment of Parkinson's disease. The abstract outlining this research, "Neuroprotection and Regeneration by Nogo Receptor Inhibition in Experimental Parkinson's Disease," was presented yesterday afternoon at the Society of Neuroscience Annual Meeting in Washington, D.C.MORE:
|